Skip to main content

Revascularization in stable coronary disease: evidence and uncertainties.

Publication ,  Journal Article
Katritsis, DG; Mark, DB; Gersh, BJ
Published in: Nat Rev Cardiol
July 2018

Although revascularization has been one of the primary treatment options for obstructive coronary artery disease (CAD) for about 50 years, the evidence base for its use is most robust in the area of acute coronary disease. By contrast, evidence - particularly from clinical trials - supporting the use of revascularization to improve clinical outcomes in stable CAD is in some important respects outdated in that it reflects therapies that predate both contemporary standards for optimal medical therapy and current revascularization techniques and technologies. Despite such limitations, these clinical trials still provide the foundation for many of the current guideline-based indications for coronary revascularization in patients with stable CAD. In this Review, we discuss the major factors underlying the clinical decision to perform revascularization in patients with stable CAD and examine the use and limitations of existing evidence on the choice for, and preferred methods of, revascularization, namely, CABG surgery versus percutaneous coronary intervention.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Nat Rev Cardiol

DOI

EISSN

1759-5010

Publication Date

July 2018

Volume

15

Issue

7

Start / End Page

408 / 419

Location

England

Related Subject Headings

  • Treatment Outcome
  • Risk Factors
  • Risk Assessment
  • Recovery of Function
  • Percutaneous Coronary Intervention
  • Patient Selection
  • Humans
  • Coronary Artery Disease
  • Coronary Artery Bypass
  • Clinical Decision-Making
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Katritsis, D. G., Mark, D. B., & Gersh, B. J. (2018). Revascularization in stable coronary disease: evidence and uncertainties. Nat Rev Cardiol, 15(7), 408–419. https://doi.org/10.1038/s41569-018-0006-z
Katritsis, Demosthenes G., Daniel B. Mark, and Bernard J. Gersh. “Revascularization in stable coronary disease: evidence and uncertainties.Nat Rev Cardiol 15, no. 7 (July 2018): 408–19. https://doi.org/10.1038/s41569-018-0006-z.
Katritsis DG, Mark DB, Gersh BJ. Revascularization in stable coronary disease: evidence and uncertainties. Nat Rev Cardiol. 2018 Jul;15(7):408–19.
Katritsis, Demosthenes G., et al. “Revascularization in stable coronary disease: evidence and uncertainties.Nat Rev Cardiol, vol. 15, no. 7, July 2018, pp. 408–19. Pubmed, doi:10.1038/s41569-018-0006-z.
Katritsis DG, Mark DB, Gersh BJ. Revascularization in stable coronary disease: evidence and uncertainties. Nat Rev Cardiol. 2018 Jul;15(7):408–419.

Published In

Nat Rev Cardiol

DOI

EISSN

1759-5010

Publication Date

July 2018

Volume

15

Issue

7

Start / End Page

408 / 419

Location

England

Related Subject Headings

  • Treatment Outcome
  • Risk Factors
  • Risk Assessment
  • Recovery of Function
  • Percutaneous Coronary Intervention
  • Patient Selection
  • Humans
  • Coronary Artery Disease
  • Coronary Artery Bypass
  • Clinical Decision-Making